Stephen M. Lanier - Publications

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Molecular Biology, Pharmacology

76/86 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Vural A, Lanier SM. Intersection of two key signal integrators in the cell: activator of G protein Signaling 3 and Dishevelled-2. Journal of Cell Science. PMID 32737219 DOI: 10.1242/jcs.247908  0.814
2018 Vural A, Fadillioglu E, Kelesoglu F, Ma D, Lanier SM. Role of G-proteins and S/T phosphorylation sites in the transition of Activator of G-Protein signaling 3 to cell puncta. Journal of Cell Science. PMID 30404823 DOI: 10.1242/Jcs.216507  0.788
2015 Robichaux WG, Oner SS, Lanier SM, Blumer JB. Direct Coupling of a Seven-Transmembrane-Span Receptor to a Gαi G-Protein Regulatory Motif Complex. Molecular Pharmacology. 88: 231-7. PMID 25972449 DOI: 10.1124/Mol.115.097741  0.521
2014 Branham-O'Connor M, Robichaux WG, Zhang XK, Cho H, Kehrl JH, Lanier SM, Blumer JB. Defective chemokine signal integration in leukocytes lacking activator of G protein signaling 3 (AGS3). The Journal of Biological Chemistry. 289: 10738-47. PMID 24573680 DOI: 10.1074/Jbc.M113.515031  0.583
2014 Blumer JB, Lanier SM. Activators of G protein signaling exhibit broad functionality and define a distinct core signaling triad. Molecular Pharmacology. 85: 388-96. PMID 24302560 DOI: 10.1124/Mol.113.090068  0.643
2013 Oner SS, Vural A, Lanier SM. Translocation of activator of G-protein signaling 3 to the Golgi apparatus in response to receptor activation and its effect on the trans-Golgi network. The Journal of Biological Chemistry. 288: 24091-103. PMID 23770668 DOI: 10.1074/Jbc.M112.444505  0.8
2013 Oner SS, Blumer JB, Lanier SM. Group II activators of G-protein signaling: monitoring the interaction of Gα with the G-protein regulatory motif in the intact cell. Methods in Enzymology. 522: 153-67. PMID 23374185 DOI: 10.1016/B978-0-12-407865-9.00009-1  0.659
2013 Oner SS, Maher EM, Gabay M, Tall GG, Blumer JB, Lanier SM. Regulation of the G-protein regulatory-Gαi signaling complex by nonreceptor guanine nucleotide exchange factors. The Journal of Biological Chemistry. 288: 3003-15. PMID 23212907 DOI: 10.1074/Jbc.M112.418467  0.47
2012 Simon V, Oner SS, Cohen-Tannoudji J, Tobin AB, Lanier SM. Influence of the accessory protein SET on M3 muscarinic receptor phosphorylation and G protein coupling Molecular Pharmacology. 82: 17-26. PMID 22466417 DOI: 10.1124/Mol.111.075523  0.511
2011 Blumer JB, Oner SS, Lanier SM. Group II activators of G-protein signalling and proteins containing a G-protein regulatory motif. Acta Physiologica (Oxford, England). 204: 202-18. PMID 21615707 DOI: 10.1111/J.1748-1716.2011.02327.X  0.657
2011 Sato M, Hiraoka M, Suzuki H, Bai Y, Kurotani R, Yokoyama U, Okumura S, Cismowski MJ, Lanier SM, Ishikawa Y. Identification of transcription factor E3 (TFE3) as a receptor-independent activator of Gα16: gene regulation by nuclear Gα subunit and its activator. The Journal of Biological Chemistry. 286: 17766-76. PMID 21454667 DOI: 10.1074/Jbc.M111.219816  0.589
2011 Regner KR, Nozu K, Lanier SM, Blumer JB, Avner ED, Sweeney WE, Park F. Loss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 1844-55. PMID 21343176 DOI: 10.1096/Fj.10-169797  0.407
2011 Chan P, Gabay M, Wright FA, Kan W, Oner SS, Lanier SM, Smrcka AV, Blumer JB, Tall GG. Purification of heterotrimeric G protein alpha subunits by GST-Ric-8 association: primary characterization of purified G alpha(olf). The Journal of Biological Chemistry. 286: 2625-35. PMID 21115479 DOI: 10.1074/Jbc.M110.178897  0.58
2010 Oner SS, An N, Vural A, Breton B, Bouvier M, Blumer JB, Lanier SM. Regulation of the AGS3·G{alpha}i signaling complex by a seven-transmembrane span receptor. The Journal of Biological Chemistry. 285: 33949-58. PMID 20716524 DOI: 10.1074/Jbc.M110.138073  0.817
2010 Nadella R, Blumer JB, Jia G, Kwon M, Akbulut T, Qian F, Sedlic F, Wakatsuki T, Sweeney WE, Wilson PD, Lanier SM, Park F. Activator of G protein signaling 3 promotes epithelial cell proliferation in PKD. Journal of the American Society of Nephrology : Jasn. 21: 1275-80. PMID 20488951 DOI: 10.1681/Asn.2009121224  0.533
2010 Vural A, Oner S, An N, Simon V, Ma D, Blumer JB, Lanier SM. Distribution of activator of G-protein signaling 3 within the aggresomal pathway: role of specific residues in the tetratricopeptide repeat domain and differential regulation by the AGS3 binding partners Gi(alpha) and mammalian inscuteable. Molecular and Cellular Biology. 30: 1528-40. PMID 20065032 DOI: 10.1128/Mcb.01018-09  0.831
2009 Sato M, Jiao Q, Honda T, Kurotani R, Toyota E, Okumura S, Takeya T, Minamisawa S, Lanier SM, Ishikawa Y. Activator of G protein signaling 8 (AGS8) is required for hypoxia-induced apoptosis of cardiomyocytes: role of G betagamma and connexin 43 (CX43). The Journal of Biological Chemistry. 284: 31431-40. PMID 19723622 DOI: 10.1074/Jbc.M109.014068  0.531
2008 An N, Blumer JB, Bernard ML, Lanier SM. The PDZ and band 4.1 containing protein Frmpd1 regulates the subcellular location of activator of G-protein signaling 3 and its interaction with G-proteins. The Journal of Biological Chemistry. 283: 24718-28. PMID 18566450 DOI: 10.1074/Jbc.M803497200  0.656
2008 Blumer JB, Lord K, Saunders TL, Pacchioni A, Black C, Lazartigues E, Varner KJ, Gettys TW, Lanier SM. Activator of G protein signaling 3 null mice: I. Unexpected alterations in metabolic and cardiovascular function Endocrinology. 149: 3842-3849. PMID 18450958 DOI: 10.1210/En.2008-0050  0.478
2007 Yuan C, Sato M, Lanier SM, Smrcka AV. Signaling by a non-dissociated complex of G protein βγ and α subunits stimulated by a receptor-independent activator of G protein signaling, AGS8. The Journal of Biological Chemistry. 282: 19938-47. PMID 17446173 DOI: 10.1074/Jbc.M700396200  0.534
2007 Blumer JB, Smrcka AV, Lanier SM. Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling. Pharmacology & Therapeutics. 113: 488-506. PMID 17240454 DOI: 10.1016/J.Pharmthera.2006.11.001  0.666
2006 Simon V, Guidry J, Gettys TW, Tobin AB, Lanier SM. The proto-oncogene SET interacts with muscarinic receptors and attenuates receptor signaling. The Journal of Biological Chemistry. 281: 40310-20. PMID 17065150 DOI: 10.1074/Jbc.M603858200  0.49
2006 Blumer JB, Kuriyama R, Gettys TW, Lanier SM. The G-protein regulatory (GPR) motif-containing Leu-Gly-Asn-enriched protein (LGN) and Gialpha3 influence cortical positioning of the mitotic spindle poles at metaphase in symmetrically dividing mammalian cells. European Journal of Cell Biology. 85: 1233-40. PMID 17000024 DOI: 10.1016/J.Ejcb.2006.08.002  0.534
2006 Song KS, Peterson YK, Freidman A, Blumer JB, Sato M, Lanier SM. Identification and characterization of a G-protein regulatory motif in WAVE1. Febs Letters. 580: 1993-8. PMID 16530190 DOI: 10.1016/J.Febslet.2006.02.071  0.697
2006 Sato M, Cismowski MJ, Toyota E, Smrcka AV, Lucchesi PA, Chilian WM, Lanier SM. Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma. Proceedings of the National Academy of Sciences of the United States of America. 103: 797-802. PMID 16407149 DOI: 10.1073/Pnas.0507467103  0.594
2006 Sato M, Blumer JB, Simon V, Lanier SM. Accessory proteins for G proteins: partners in signaling. Annual Review of Pharmacology and Toxicology. 46: 151-87. PMID 16402902 DOI: 10.1146/Annurev.Pharmtox.46.120604.141115  0.689
2005 Blumer JB, Cismowski MJ, Sato M, Lanier SM. AGS proteins: receptor-independent activators of G-protein signaling. Trends in Pharmacological Sciences. 26: 470-6. PMID 16084602 DOI: 10.1016/J.Tips.2005.07.003  0.669
2005 Yang Q, Alemany R, Casas J, Kitajka K, Lanier SM, Escribá PV. Influence of the membrane lipid structure on signal processing via G protein-coupled receptors. Molecular Pharmacology. 68: 210-7. PMID 15837842 DOI: 10.1124/Mol.105.011692  0.531
2004 Lanier SM. AGS proteins, GPR motifs and the signals processed by heterotrimeric G proteins. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 96: 369-72. PMID 15207906 DOI: 10.1016/J.Biolcel.2004.03.012  0.684
2004 Vaidyanathan G, Cismowski MJ, Wang G, Vincent TS, Brown KD, Lanier SM. The Ras-related protein AGS1/RASD1 suppresses cell growth. Oncogene. 23: 5858-63. PMID 15184869 DOI: 10.1038/Sj.Onc.1207774  0.371
2004 Cao X, Cismowski MJ, Sato M, Blumer JB, Lanier SM. Identification and characterization of AGS4: a protein containing three G-protein regulatory motifs that regulate the activation state of Gialpha. The Journal of Biological Chemistry. 279: 27567-74. PMID 15096500 DOI: 10.1074/Jbc.M312786200  0.643
2004 Bowers MS, McFarland K, Lake RW, Peterson YK, Lapish CC, Gregory ML, Lanier SM, Kalivas PW. Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking. Neuron. 42: 269-81. PMID 15091342 DOI: 10.1016/S0896-6273(04)00159-X  0.652
2004 Sato M, Gettys TW, Lanier SM. AGS3 and signal integration by Galpha(s)- and Galpha(i)-coupled receptors: AGS3 blocks the sensitization of adenylyl cyclase following prolonged stimulation of a Galpha(i)-coupled receptor by influencing processing of Galpha(i). The Journal of Biological Chemistry. 279: 13375-82. PMID 14726514 DOI: 10.1074/Jbc.M312660200  0.574
2003 Bowers MS, Lake RW, McFarland K, Peterson YK, Lanier SM, Lapish CC, Kalivas PW. AGS3: a G-Protein regulator of addiction-associated behaviors. Annals of the New York Academy of Sciences. 1003: 356-7. PMID 14684460 DOI: 10.1196/Annals.1300.025  0.727
2003 Ghosh M, Peterson YK, Lanier SM, Smrcka AV. Receptor- and nucleotide exchange-independent mechanisms for promoting G protein subunit dissociation. The Journal of Biological Chemistry. 278: 34747-50. PMID 12881533 DOI: 10.1074/Jbc.C300271200  0.785
2003 Ma H, Peterson YK, Bernard ML, Lanier SM, Graber SG. Influence of cytosolic AGS3 on receptor--G protein coupling. Biochemistry. 42: 8085-93. PMID 12834360 DOI: 10.1021/Bi034561P  0.771
2003 Gotta M, Dong Y, Peterson YK, Lanier SM, Ahringer J. Asymmetrically distributed C. elegans homologs of AGS3/PINS control spindle position in the early embryo. Current Biology : Cb. 13: 1029-37. PMID 12814548 DOI: 10.1016/S0960-9822(03)00371-3  0.675
2003 Blumer JB, Lanier SM. Accessory proteins for G protein-signaling systems: activators of G protein signaling and other nonreceptor proteins influencing the activation state of G proteins. Receptors & Channels. 9: 195-204. PMID 12775339 DOI: 10.1080/10606820308240  0.681
2003 Blumer JB, Bernard ML, Peterson YK, Nezu J, Chung P, Dunican DJ, Knoblich JA, Lanier SM. Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression: phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction of GPR motifs with Gi alpha. The Journal of Biological Chemistry. 278: 23217-20. PMID 12719437 DOI: 10.1074/Jbc.C200686200  0.801
2002 Ribas C, Takesono A, Sato M, Hildebrandt JD, Lanier SM. Pertussis toxin-insensitive activation of the heterotrimeric G-proteins Gi/Go by the NG108-15 G-protein activator. The Journal of Biological Chemistry. 277: 50223-5. PMID 12426323 DOI: 10.1074/Jbc.C200567200  0.647
2002 Takesono A, Nowak MW, Cismowski M, Duzic E, Lanier SM. Activator of G-protein signaling 1 blocks GIRK channel activation by a G-protein-coupled receptor: apparent disruption of receptor signaling complexes. The Journal of Biological Chemistry. 277: 13827-30. PMID 11842095 DOI: 10.1074/Jbc.M201064200  0.657
2002 Blumer JB, Chandler LJ, Lanier SM. Expression analysis and subcellular distribution of the two G-protein regulators AGS3 and LGN indicate distinct functionality. Localization of LGN to the midbody during cytokinesis. The Journal of Biological Chemistry. 277: 15897-903. PMID 11832491 DOI: 10.1074/Jbc.M112185200  0.573
2002 Wu G, Bernard ML, Lanier SM. Protein interaction assays with G proteins. Methods in Enzymology. 344: 521-35. PMID 11771408 DOI: 10.1016/S0076-6879(02)44738-6  0.572
2002 Cismowski MJ, Takesono A, Ma C, Lanier SM, Duzic E. Identification of modulators of mammalian G-protein signaling by functional screens in the yeast Saccharomyces cerevisiae. Methods in Enzymology. 344: 153-68. PMID 11771380 DOI: 10.1016/S0076-6879(02)44712-X  0.543
2002 Ribas C, Sato M, Hildebrandt JD, Lanier SM. Analysis of signal transfer from receptor to Go/Gi in different membrane environments and receptor-independent activators of brain G protein. Methods in Enzymology. 344: 140-52. PMID 11771378 DOI: 10.1016/S0076-6879(02)44711-8  0.523
2002 Peterson YK, Hazard S, Graber SG, Lanier SM. Identification of structural features in the G-protein regulatory motif required for regulation of heterotrimeric G-proteins. The Journal of Biological Chemistry. 277: 6767-70. PMID 11756403 DOI: 10.1074/Jbc.C100699200  0.717
2001 Webb JG, Yates PW, Yang Q, Mukhin YV, Lanier SM. Adenylyl cyclase isoforms and signal integration in models of vascular smooth muscle cells. American Journal of Physiology. Heart and Circulatory Physiology. 281: H1545-52. PMID 11557542 DOI: 10.1152/Ajpheart.2001.281.4.H1545  0.331
2001 Cismowski MJ, Takesono A, Bernard ML, Duzic E, Lanier SM. Receptor-independent activators of heterotrimeric G-proteins Life Sciences. 68: 2301-2308. PMID 11358340 DOI: 10.1016/S0024-3205(01)01019-0  0.672
2001 Pizzinat N, Takesono A, Lanier SM. Identification of a truncated form of the G-protein regulator AGS3 in heart that lacks the tetratricopeptide repeat domains. The Journal of Biological Chemistry. 276: 16601-10. PMID 11278352 DOI: 10.1074/Jbc.M007573200  0.484
2001 Limon-Boulez I, Bouet-Alard R, Gettys TW, Lanier SM, Maltier JP, Legrand C. Partial agonist clonidine mediates alpha(2)-AR subtypes specific regulation of cAMP accumulation in adenylyl cyclase II transfected DDT1-MF2 cells. Molecular Pharmacology. 59: 331-8. PMID 11160870 DOI: 10.1124/Mol.59.2.331  0.337
2001 Vindis C, Séguélas M, Lanier S, Parini A, Cambon C. Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase. Kidney International. 59: 76-86. PMID 11135060 DOI: 10.1046/J.1523-1755.2001.00468.X  0.322
2001 Bernard ML, Peterson YK, Chung P, Jourdan J, Lanier SM. Selective interaction of AGS3 with G-proteins and the influence of AGS3 on the activation state of G-proteins Journal of Biological Chemistry. 276: 1585-1593. PMID 11042168 DOI: 10.1074/Jbc.M005291200  0.802
2000 Remaury A, Raddatz R, Ordener C, Savic S, Shih JC, Chen K, Seif I, De Maeyer E, Lanier SM, Parini A. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models. Molecular Pharmacology. 58: 1085-90. PMID 11040057 DOI: 10.1124/Mol.58.5.1085  0.349
2000 Natochin M, Lester B, Peterson YK, Bernard ML, Lanier SM, Artemyev NO. AGS3 inhibits GDP dissociation from galpha subunits of the Gi family and rhodopsin-dependent activation of transducin. The Journal of Biological Chemistry. 275: 40981-5. PMID 11024022 DOI: 10.1074/Jbc.M006478200  0.77
2000 Peterson YK, Bernard ML, Ma H, Hazard S, Graber SG, Lanier SM. Stabilization of the GDP-bound conformation of Gialpha by a peptide derived from the G-protein regulatory motif of AGS3. The Journal of Biological Chemistry. 275: 33193-6. PMID 10969064 DOI: 10.1074/Jbc.C000509200  0.762
2000 Cismowski MJ, Ma C, Ribas C, Xie X, Spruyt M, Lizano JS, Lanier SM, Duzic E. Activation of heterotrimeric G-protein signaling by a ras-related protein. Implications for signal integration. The Journal of Biological Chemistry. 275: 23421-4. PMID 10840027 DOI: 10.1074/Jbc.C000322200  0.607
2000 Wu G, Bogatkevich GS, Mukhin YV, Benovic JL, Hildebrandt JD, Lanier SM. Identification of Gbetagamma binding sites in the third intracellular loop of the M(3)-muscarinic receptor and their role in receptor regulation. The Journal of Biological Chemistry. 275: 9026-34. PMID 10722752 DOI: 10.1074/Jbc.275.12.9026  0.405
1999 Takesono A, Cismowski MJ, Ribas C, Bernard M, Chung P, Hazard S, Duzic E, Lanier SM. Receptor-independent activators of heterotrimeric G-protein signaling pathways. The Journal of Biological Chemistry. 274: 33202-5. PMID 10559191 DOI: 10.1074/Jbc.274.47.33202  0.674
1999 Cismowski MJ, Takesono A, Ma C, Lizano JS, Xie X, Fuernkranz H, Lanier SM, Duzic E. Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling. Nature Biotechnology. 17: 878-83. PMID 10471929 DOI: 10.1038/12867  0.568
1999 Yang Q, Lanier SM. Influence of G protein type on agonist efficacy. Molecular Pharmacology. 56: 651-6. PMID 10462553 DOI: 10.1124/Mol.56.3.651  0.585
1999 Raddatz R, Savic SL, Lanier SM. Imidazoline binding domains on MAO-B. Localization and accessibility. Annals of the New York Academy of Sciences. 881: 26-31. PMID 10415893 DOI: 10.1111/J.1749-6632.1999.Tb09337.X  0.43
1999 Yang Q, Martinez E, Lanier SM, Escriba PV. Role of phosphatidylethanoamines in G protein receptor-associated signal transduction Prostaglandins & Other Lipid Mediators. 59: 31. DOI: 10.1016/S0090-6980(99)90266-6  0.617
1998 Wu G, Benovic JL, Hildebrandt JD, Lanier SM. Receptor docking sites for G-protein βγ subunits. Implications for signal regulation Journal of Biological Chemistry. 273: 7197-7200. PMID 9516410 DOI: 10.1074/Jbc.273.13.7197  0.479
1998 Soini SL, Duzic E, Lanier SM, Akerman KE. Dual modulation of calcium channel current via recombinant alpha2-adrenoceptors in pheochromocytoma (PC-12) cells. Pflugers Archiv : European Journal of Physiology. 435: 280-5. PMID 9382943 DOI: 10.1007/S004240050513  0.326
1997 Lanier SM, Raddatz R, Parini A. Relationship between alpha 2-adrenergic receptors and imidazoline/guanidinium receptive sites. Advances in Pharmacology (San Diego, Calif.). 42: 474-7. PMID 9327942 DOI: 10.1016/S1054-3589(08)60791-7  0.431
1997 Zhang J, Sato M, Duzic E, Kubalak SW, Lanier SM, Webb JG. Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells. The American Journal of Physiology. 273: H971-80. PMID 9277517 DOI: 10.1152/Ajpheart.1997.273.2.H971  0.352
1997 Wu G, Krupnick JG, Benovic JL, Lanier SM. Interaction of Arrestins with intracellular domains of muscarinic and α 2-adrenergic receptors Journal of Biological Chemistry. 272: 17836-17842. PMID 9211939 DOI: 10.1074/Jbc.272.28.17836  0.449
1997 Marjamaki A, Sato M, Bouet-Alard R, Yang Q, Limon-Boulez I, Legrand C, Lanier SM. Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. Integration of stimulatory and inhibitory input to the effector adenylyl cyclase. The Journal of Biological Chemistry. 272: 16466-73. PMID 9195955 DOI: 10.1074/Jbc.272.26.16466  0.39
1997 Yang Q, McDermott PJ, Duzic E, Pleij CW, Sherlock JD, Lanier SM. The 3'-untranslated region of the alpha2C-adrenergic receptor mRNA impedes translation of the receptor message. The Journal of Biological Chemistry. 272: 15466-73. PMID 9182579 DOI: 10.1074/Jbc.272.24.15466  0.427
1997 Sato M, Ribas C, Hildebrandt JD, Lanier SM. Characterization of a G-protein activator in the neuroblastoma-glioma cell hybrid NG108-15. The Journal of Biological Chemistry. 271: 30052-60. PMID 8939952 DOI: 10.1074/Jbc.271.47.30052  0.624
1996 Parini A, Moudanos CG, Pizzinat N, Lanier SM. The elusive family of imidazoline binding sites. Trends in Pharmacological Sciences. 17: 13-6. PMID 8789353 DOI: 10.1016/0165-6147(96)81564-1  0.315
1996 Brasili L, Pigini M, Marucci G, Quaglia W, Malmusi L, Lanier SM, Lanier B. Separation of alpha-adrenergic and imidazoline/guanidinium receptive sites (IGRS) activity in a series of imidazoline analogues of cirazoline. Bioorganic & Medicinal Chemistry. 3: 1503-9. PMID 8634830 DOI: 10.1016/0968-0896(95)00132-Z  0.336
1996 Raddatz R, Parini A, Lanier SM. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. The Journal of Biological Chemistry. 270: 27961-8. PMID 7499273 DOI: 10.1074/Jbc.270.46.27961  0.373
1995 Sato M, Kataoka R, Dingus J, Wilcox M, Hildebrandt JD, Lanier SM. Factors determining specificity of signal transduction by G-protein- coupled receptors. Regulation of signal transfer from receptor to G-protein Journal of Biological Chemistry. 270: 15269-15276. PMID 7797513 DOI: 10.1074/Jbc.270.25.15269  0.64
1995 Lanier SM, Lanier B, Bakthavachalam V, McGrath CR, Neumeyer JL. Use of high affinity, radioiodinated probes for identification of imidazoline/guanidinium receptive sites. Annals of the New York Academy of Sciences. 763: 106-11. PMID 7677319 DOI: 10.1111/J.1749-6632.1995.Tb32395.X  0.358
1995 Hamamdzic D, Duzic E, Sherlock JD, Lanier SM. Regulation of alpha 2-adrenergic receptor expression and signaling in pancreatic beta-cells. The American Journal of Physiology. 269: E162-71. PMID 7631772 DOI: 10.1152/Ajpendo.1995.269.1.E162  0.426
Low-probability matches (unlikely to be authored by this person)
1986 Lanier SM, Graham RM, Hess HJ, Grodski A, Repaske MG, Nunnari JM, Limbird LE, Homcy CJ. Photoaffinity labeling of the porcine brain alpha 2-adrenergic receptor using a radioiodinated arylazide derivative of rauwolscine: identification of the hormone-binding subunit. Proceedings of the National Academy of Sciences of the United States of America. 83: 9358-62. PMID 3025837 DOI: 10.1073/pnas.83.24.9358  0.258
1997 Raddatz R, Lanier SM. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B. Neurochemistry International. 30: 109-17. PMID 9116581 DOI: 10.1016/S0197-0186(96)00036-8  0.254
1985 Schwarz KR, Lanier SM, Carter EA, Graham RM, Homcy CJ. Transient high-affinity binding of agonists to alpha 1-adrenergic receptors of intact liver cells. Febs Letters. 187: 205-10. PMID 2862060 DOI: 10.1016/0014-5793(85)81243-6  0.23
1986 Schwarz KR, Lanier SM, Sena LM, Carter EA, Graham RM, Homcy CJ. Agonist-induced isomerization of the alpha 1-adrenergic receptor: kinetic analysis using broken-cell and solubilized preparations. Biochemistry. 25: 2697-702. PMID 3013311 DOI: 10.1021/bi00357a062  0.226
1987 Lanier SM, Graham RM, Hess HJ, Grodski A, Repaske MG, Nunnari JM, Limbird LE, Homcy CJ. Synthesis and characterization of arylamine derivatives of rauwolscine as molecular probes for alpha 2-adrenergic receptors. Hypertension. 9: III120-4. PMID 2885270 DOI: 10.1161/01.HYP.9.6_Pt_2.III120  0.221
1997 Raddatz R, Parini A, Lanier SM. Localization of the imidazoline binding domain on monoamine oxidase B. Molecular Pharmacology. 52: 549-53. PMID 9380016 DOI: 10.1124/mol.52.4.549  0.219
2024 Vural A, Lanier SM. Properties of biomolecular condensates defined by Activator of G-protein Signaling 3. Journal of Cell Science. 137. PMID 38264908 DOI: 10.1242/jcs.261326  0.12
1983 Lanier SM, Malik KU. Attenuation by prostaglandins of the facilitatory effect of angiotensin II at adrenergic prejunctional sites in the isolated Krebs-perfused rat heart. Circulation Research. 51: 594-601. PMID 6958394 DOI: 10.1161/01.RES.51.5.594  0.045
1985 Lanier SM, Malik KU. Inhibition by prostaglandins of adrenergic transmission in the left ventricular myocardium of anesthetized dogs. Journal of Cardiovascular Pharmacology. 7: 653-9. PMID 2410704 DOI: 10.1097/00005344-198507000-00007  0.042
1981 Cagen LM, Lanier SM, Baer PG. Prostaglandin E2 metabolism by isolated kidneys of New Zealand genetically hypertensive and normotensive rats. Biochemical Medicine. 25: 98-105. PMID 7225102 DOI: 10.1016/0006-2944(81)90065-X  0.021
Hide low-probability matches.